References
- Young R, Snyder B. IMRT (intensity modulated radiation therapy): progress in technology and reimbursement. Radiol. Manage. 23(6), 20–26 (2001).
- Zelefsky MJ. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 41(3), 491–500 (1998).
- Zelefsky MJ. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int. J. Radiat. Oncol. Biol. Phys. 53(5), 1111–1116 (2002).
- Fleming C. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA 269(20), 2650–2658 (1993).
- Hanks GE. Dose response in prostate cancer with 8–12 years' follow-up. Int. J. Radiat. Oncol. Biol. Phys. 54(2), 427–435 (2002).
- Chism DB. Late morbidity profiles in prostate cancer patients treated to 79–84 Gy by a simple four-field coplanar beam arrangement. Int. J. Radiat. Oncol. Biol. Phys. 55(1), 71–77 (2003).
- Oefelein MG, Agarwal PK, Resnick MI. Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era. J. Urol. 171(4), 1525–1528 (2004).
- Scher HI. Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancer. J. Natl. Cancer Inst. 91(3), 244–251 (1999).
- Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int. J. Radiat. Oncol. Biol. Phys. 37, 1035–1041 (1997).
- Kuntz MC. Modelling in economic evaluation. In: Economic Evaluation in Health Care. Drummond A (Ed.). Oxford University Press, Oxford, UK (2001).
- Briggs AH. Handling uncertainty in economic evaluation and presenting the results. In: Economic Evaluation in Health Care. Drummond A (Ed.). Oxford University Press, Oxford, UK (2001).
- Piper NY. Adenocarcinoma of the prostate: an expensive way to die. Prostate Cancer Prostatic Dis. 5(2), 164–166 (2002).
- Doubilet P. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med. Dec. Making 5(2), 157–177 (1985).
- EuroQol – a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Pol. 16, 199–208 (1990).
- Hummel S. Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review. Health Technol. Assess. 7(33), 1–157 (2003).
Websites
- American Chemical Society www.acs.org (Accessed March 2005)
- Harvard University www.hcra.harvard.edu/pdf (Accessed March 2005)